Article
Platelet RNA as Pan-Tumor Biomarker for Cancer Detection.
Cancer research - 1 Apr 2020
Wurdinger Thomas, In 't Veld Sjors G J G, Best Myron G
Abstract excerpt
Blood-based liquid biopsies are considered a screening approach for early cancer detection. Sequencing technologies enable in-depth analyses of nucleic acids, including mutant cell-free (cf) DNA in the plasma. However, in the blood of patients with early-stage cancer the detection level of mutant cfDNA is relatively low, and complicated by the natural presence of noncancer cfDNA mutants attributed to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
